Man­u­fac­tur­ing roundup: Chi­nese CD­MO nets $80M+ Se­ries B; $11M ex­pan­sion on the books for man­u­fac­tur­er in NC

A Chi­nese CD­MO has man­aged to put to­geth­er a siz­able Se­ries B.

Por­ton Ad­vanced So­lu­tions has com­plet­ed the fi­nanc­ing round gar­ner­ing over $80 mil­lion.

The com­pa­ny will use the funds to con­tin­ue its busi­ness ex­pan­sion in­to dif­fer­ent mar­kets, with in­vest­ment in man­u­fac­tur­ing in­fra­struc­ture and glob­al com­mer­cial op­er­a­tions.

The CD­MO, which is fo­cused sole­ly on gene and cell ther­a­py ser­vices, has es­tab­lished a CD­MO plat­form pro­vid­ing a wide ar­ray of ser­vices cov­er­ing plas­mids, cell ther­a­py, gene ther­a­py, on­colyt­ic virus, nu­cle­ic acid ther­a­py and mi­cro­bial vec­tors used for gene ther­a­py. The com­pa­ny’s cur­rent op­er­a­tional foot­print in­cludes a 40,000-square-foot site, with an­oth­er 160,000-square-foot fa­cil­i­ty com­ing on­line at the end of the year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER